Renaissance Technologies
BFRI icon

Renaissance Technologies’s Biofrontera BFRI Stock Holding History

Renaissance Technologies’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,700
Closed -$18.4K – 3253
2025
Q3 		$18.4K Buy
+18,700
New +$16.9K ﹤0.01% 3431
2024
Q2 		– Sell
-10,221
Closed -$16K – 3501
2024
Q1 		$16K Buy
+10,221
New +$14.2K ﹤0.01% 3604
2023
Q3 		– Sell
-2,522
Closed -$26K – 3671
2023
Q2 		$26K Buy
2,522
+735
+41% +$7.8K ﹤0.01% 3728
2023
Q1 		$22K Buy
1,787
+790
+79% +$12.3K ﹤0.01% 3807
2022
Q4 		$18K Buy
997
+300
+43% +$6.13K ﹤0.01% 3977
2022
Q3 		$15K Buy
+697
New +$19K ﹤0.01% 3926

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Renaissance Technologies's BFRI Position: Q4 2025 in Review

Renaissance Technologies sold out of Biofrontera (BFRI) in Q4 2025, closing a stake of 18,700 shares — an estimated $18.4K sold.

Renaissance Technologies first reported a position in BFRI in Q3 2022 and held it in 6 quarters. The position peaked at $26K in Q2 2023. 14 funds tracked by Wall St. Rank hold BFRI as of Q4 2025.

  • Renaissance Technologies reported no remaining Biofrontera position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 18,700 Biofrontera shares in Q4 2025, an estimated $18.4K.
  • Renaissance Technologies first reported a position in Biofrontera in Q3 2022 and held it in 6 quarters.
  • Renaissance Technologies's Biofrontera position peaked at $26K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Biofrontera as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.